Statin therapy to support PCI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(/* ACCF/AHA/SCAI 2011 Guideline for Percutaneous Coronary Intervention: Statin Treatment{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, ...) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==ACCF/AHA/SCAI 2011 | ==ACCF/AHA/SCAI 2011 Guidelines for Percutaneous Coronary Intervention: Statin Treatment<ref name="pmid22070837">{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH |title=2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions |journal=[[Journal of the American College of Cardiology]] |volume=58 |issue=24 |pages=2550–83 |year=2011 |month=December|pmid=22070837|doi=10.1016/j.jacc.2011.08.006|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(11)02875-0|accessdate=2011-12-08|url=http://content.onlinejacc.org/cgi/reprint/58/24/2550.pdf|PDF}}</ref> (DO NOT EDIT)== | ||
{|class="wikitable" | {|class="wikitable" | ||
| Line 13: | Line 13: | ||
<nowiki>"</nowiki>'''1.''' Administration of a [[Statin|high-dose statin]] is reasonable before PCI to reduce the risk of peri-procedural [[myocardial infarction]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]] for [[statin]]-naïve patients)'' <ref name="pmid15474697">{{cite journal |author=Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Bonizzoni E, Ricciardelli B |title=Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction |journal=[[European Heart Journal]] |volume=25 |issue=20 |pages=1822–8 |year=2004|month=October |pmid=15474697 |doi=10.1016/j.ehj.2004.07.017|url=http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15474697|accessdate=2011-12-06}}</ref><ref name="pmid19664895">{{cite journal |author=Briguori C, Visconti G, Focaccio A, Golia B, Chieffo A, Castelli A, Mussardo M, Montorfano M, Ricciardelli B, Colombo A|title=Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction |journal=[[Journal of the American College of Cardiology]] |volume=54 |issue=23 |pages=2157–63 |year=2009 |month=December|pmid=19664895 |doi=10.1016/j.jacc.2009.07.005|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)02248-7|accessdate=2011-12-06}}</ref><ref name="pmid15277322">{{cite journal |author=Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G |title=Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study |journal=[[Circulation]] |volume=110|issue=6 |pages=674–8 |year=2004 |month=August |pmid=15277322|doi=10.1161/01.CIR.0000137828.06205.87 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=15277322 |accessdate=2011-12-06}}</ref><ref name="pmid17394957">{{cite journal|author=Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G |title=Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial |journal=[[Journal of the American College of Cardiology]] |volume=49 |issue=12 |pages=1272–8|year=2007 |month=March |pmid=17394957 |doi=10.1016/j.jacc.2007.02.025|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(07)00661-4|accessdate=2011-12-06}}</ref><ref name="pmid18706705">{{cite journal |author=Yun KH, Jeong MH, Oh SK, Rhee SJ, Park EM, Lee EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW |title=The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome |journal=[[International Journal of Cardiology]] |volume=137 |issue=3|pages=246–51 |year=2009 |month=November |pmid=18706705 |doi=10.1016/j.ijcard.2008.06.055|url=http://linkinghub.elsevier.com/retrieve/pii/S0167-5273(08)00853-X|accessdate=2011-12-06}}</ref><ref name="pmid20384433">{{cite journal |author=Zhang F, Dong L, Ge J|title=Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis |journal=[[Annals of Medicine]] |volume=42|issue=3 |pages=171–7 |year=2010 |month=April |pmid=20384433 |doi=10.3109/07853890903463976|url=http://informahealthcare.com/doi/abs/10.3109/07853890903463976|accessdate=2011-12-06}}</ref><ref name="pmid20825761">{{cite journal |author=Winchester DE, Wen X, Xie L, Bavry AA |title=Evidence of pre-procedural statin therapy a meta-analysis of randomized trials |journal=[[Journal of the American College of Cardiology]] |volume=56 |issue=14|pages=1099–109 |year=2010 |month=September |pmid=20825761 |doi=10.1016/j.jacc.2010.04.023|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(10)01920-0|accessdate=2011-12-06}}</ref>; ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]] for those on chronic statin therapy)'' <ref name="pmid19643320">{{cite journal |author=Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A |title=Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial |journal=[[Journal of the American College of Cardiology]] |volume=54 |issue=6 |pages=558–65 |year=2009 |month=August|pmid=19643320 |doi=10.1016/j.jacc.2009.05.028|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)01858-0|accessdate=2011-12-06}}</ref><nowiki>"</nowiki> | <nowiki>"</nowiki>'''1.''' Administration of a [[Statin|high-dose statin]] is reasonable before PCI to reduce the risk of peri-procedural [[myocardial infarction]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]] for [[statin]]-naïve patients)'' <ref name="pmid15474697">{{cite journal |author=Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Bonizzoni E, Ricciardelli B |title=Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction |journal=[[European Heart Journal]] |volume=25 |issue=20 |pages=1822–8 |year=2004|month=October |pmid=15474697 |doi=10.1016/j.ehj.2004.07.017|url=http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15474697|accessdate=2011-12-06}}</ref><ref name="pmid19664895">{{cite journal |author=Briguori C, Visconti G, Focaccio A, Golia B, Chieffo A, Castelli A, Mussardo M, Montorfano M, Ricciardelli B, Colombo A|title=Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction |journal=[[Journal of the American College of Cardiology]] |volume=54 |issue=23 |pages=2157–63 |year=2009 |month=December|pmid=19664895 |doi=10.1016/j.jacc.2009.07.005|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)02248-7|accessdate=2011-12-06}}</ref><ref name="pmid15277322">{{cite journal |author=Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G |title=Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study |journal=[[Circulation]] |volume=110|issue=6 |pages=674–8 |year=2004 |month=August |pmid=15277322|doi=10.1161/01.CIR.0000137828.06205.87 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=15277322 |accessdate=2011-12-06}}</ref><ref name="pmid17394957">{{cite journal|author=Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G |title=Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial |journal=[[Journal of the American College of Cardiology]] |volume=49 |issue=12 |pages=1272–8|year=2007 |month=March |pmid=17394957 |doi=10.1016/j.jacc.2007.02.025|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(07)00661-4|accessdate=2011-12-06}}</ref><ref name="pmid18706705">{{cite journal |author=Yun KH, Jeong MH, Oh SK, Rhee SJ, Park EM, Lee EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW |title=The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome |journal=[[International Journal of Cardiology]] |volume=137 |issue=3|pages=246–51 |year=2009 |month=November |pmid=18706705 |doi=10.1016/j.ijcard.2008.06.055|url=http://linkinghub.elsevier.com/retrieve/pii/S0167-5273(08)00853-X|accessdate=2011-12-06}}</ref><ref name="pmid20384433">{{cite journal |author=Zhang F, Dong L, Ge J|title=Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis |journal=[[Annals of Medicine]] |volume=42|issue=3 |pages=171–7 |year=2010 |month=April |pmid=20384433 |doi=10.3109/07853890903463976|url=http://informahealthcare.com/doi/abs/10.3109/07853890903463976|accessdate=2011-12-06}}</ref><ref name="pmid20825761">{{cite journal |author=Winchester DE, Wen X, Xie L, Bavry AA |title=Evidence of pre-procedural statin therapy a meta-analysis of randomized trials |journal=[[Journal of the American College of Cardiology]] |volume=56 |issue=14|pages=1099–109 |year=2010 |month=September |pmid=20825761 |doi=10.1016/j.jacc.2010.04.023|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(10)01920-0|accessdate=2011-12-06}}</ref>; ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]] for those on chronic statin therapy)'' <ref name="pmid19643320">{{cite journal |author=Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A |title=Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial |journal=[[Journal of the American College of Cardiology]] |volume=54 |issue=6 |pages=558–65 |year=2009 |month=August|pmid=19643320 |doi=10.1016/j.jacc.2009.05.028|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)01858-0|accessdate=2011-12-06}}</ref><nowiki>"</nowiki> | ||
|} | |} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 13:56, 19 October 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
ACCF/AHA/SCAI 2011 Guidelines for Percutaneous Coronary Intervention: Statin Treatment[1] (DO NOT EDIT)
| Class IIa |
|
"1. Administration of a high-dose statin is reasonable before PCI to reduce the risk of peri-procedural myocardial infarction. (Level of Evidence: A for statin-naïve patients) [2][3][4][5][6][7][8]; (Level of Evidence: B for those on chronic statin therapy) [9]" |
References
- ↑ Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011). "2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" (PDF). Journal of the American College of Cardiology. 58 (24): 2550–83. doi:10.1016/j.jacc.2011.08.006. PMID 22070837. Retrieved 2011-12-08. Text "PDF" ignored (help); Unknown parameter
|month=ignored (help) - ↑ Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Bonizzoni E, Ricciardelli B (2004). "Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction". European Heart Journal. 25 (20): 1822–8. doi:10.1016/j.ehj.2004.07.017. PMID 15474697. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Briguori C, Visconti G, Focaccio A, Golia B, Chieffo A, Castelli A, Mussardo M, Montorfano M, Ricciardelli B, Colombo A (2009). "Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction". Journal of the American College of Cardiology. 54 (23): 2157–63. doi:10.1016/j.jacc.2009.07.005. PMID 19664895. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G (2004). "Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study". Circulation. 110 (6): 674–8. doi:10.1161/01.CIR.0000137828.06205.87. PMID 15277322. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G (2007). "Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial". Journal of the American College of Cardiology. 49 (12): 1272–8. doi:10.1016/j.jacc.2007.02.025. PMID 17394957. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Yun KH, Jeong MH, Oh SK, Rhee SJ, Park EM, Lee EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW (2009). "The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome". International Journal of Cardiology. 137 (3): 246–51. doi:10.1016/j.ijcard.2008.06.055. PMID 18706705. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Zhang F, Dong L, Ge J (2010). "Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis". Annals of Medicine. 42 (3): 171–7. doi:10.3109/07853890903463976. PMID 20384433. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Winchester DE, Wen X, Xie L, Bavry AA (2010). "Evidence of pre-procedural statin therapy a meta-analysis of randomized trials". Journal of the American College of Cardiology. 56 (14): 1099–109. doi:10.1016/j.jacc.2010.04.023. PMID 20825761. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A (2009). "Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial". Journal of the American College of Cardiology. 54 (6): 558–65. doi:10.1016/j.jacc.2009.05.028. PMID 19643320. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help)